Search

Your search keyword '"Schmitz, Shu-Fang Hsu"' showing total 5 results
Start Over Author "Schmitz, Shu-Fang Hsu" Journal journal of clinical oncology
5 results on '"Schmitz, Shu-Fang Hsu"'

2. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Author

Betticher, Daniel C., Schmitz, Shu-Fang Hsu, Tötsch, Martin, Hansen, Eva, Joss, Christine, von Briel, Christian, Schmid, Ralph A., Pless, Miklos, Habicht, James, Roth, Arnaud D., Spiliopoulos, Anastase, Stahel, Rolf, Weder, Walter, Stupp, Roger, Egli, Fritz, Furrer, Markus, Honegger, Hanspeter, Wernli, Martin, Cerny, Thomas, and Ris, Hans-Beat

Published
2003

3. Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib.

Author

Mauro, Michael J., primary, Lang, Fabian, additional, Kim, Dong-Wook, additional, Cortes, Jorge E., additional, Hughes, Timothy P., additional, Hochhaus, Andreas, additional, Minami, Hironobu, additional, Boquimpani, Carla, additional, Minami, Yosuke, additional, DeAngelo, Daniel J., additional, Breccia, Massimo, additional, Talpaz, Moshe, additional, Goh, Yeow-Tee, additional, Ottmann, Oliver, additional, Sondhi, Manu, additional, Hois, Stephan, additional, Bédoucha, Véronique, additional, Schmitz, Shu-Fang Hsu, additional, and Rea, Delphine, additional

Published
2018
Full Text
View/download PDF

4. Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M.

Author

Tan, Daniel Shao-Weng, primary, Yang, James Chih-Hsin, additional, Leighl, Natasha B., additional, Riely, Gregory J., additional, Sequist, Lecia V., additional, Felip, Enriqueta, additional, Seto, Takashi, additional, Wolf, Juergen, additional, Moody, Susan Elizabeth, additional, Adams, Kenneth, additional, Schmitz, Shu-Fang Hsu, additional, Tan, Eugene Y., additional, and Kim, Dong-Wan, additional

Published
2016
Full Text
View/download PDF

5. First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.

Author

Tan, Daniel Shao-Weng, primary, Seto, Takashi, additional, Leighl, Natasha B., additional, Riely, Gregory J., additional, Sequist, Lecia V., additional, Felip, Enriqueta, additional, Wolf, Juergen, additional, Yang, James Chih-Hsin, additional, Matushansky, Igor, additional, Yu, Xiaolu, additional, Schmitz, Shu-Fang Hsu, additional, Cui, Xiaoming, additional, and Kim, Dong-Wan, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results